The non-viral drug delivery systems industry is witnessing significant transformation driven by rising demand for safer, effective, and targeted therapeutic solutions. Innovations in nanotechnology and material science have accelerated the adoption of these delivery platforms, emphasizing improved patient compliance and reduced side effects. This dynamic landscape underscores the importance of...